State of Wyoming’s Niagen Bioscience NAGE Stock Holding History

State of Wyoming’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.1K	Sell	14,779 -10,626	-42%	-$43.1K	﹤0.01%	1700
2026 Q1	$112K	Sell	25,405 -12,879	-34%	-$69.5K	0.01%	1256
2025 Q4	$243K	Sell	38,284 -4,233	-10%	-$29.4K	0.03%	826
2025 Q3	$397K	Buy	42,517 +21,981	+107%	+$222K	0.05%	487
2025 Q2	$296K	Sell	20,536 -9,979	-33%	-$98.5K	0.04%	661
2025 Q1	$211K	Buy	30,515 +23,144	+314%	+$145K	0.03%	765
2024 Q4	$39.1K	Buy	+7,371	New	+$40.4K	0.01%	1478
2022 Q2	–	Sell	-4,487	Closed	-$11K	–	2184
2022 Q1	$11K	Sell	4,487 -4,272	-49%	-$11.7K	0.01%	1598
2021 Q4	$33K	Buy	+8,759	New	+$47.3K	0.02%	1309

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State of Wyoming's NAGE Position: Q2 2026 in Review

State of Wyoming reduced its Niagen Bioscience (NAGE) stake by 42% in Q2 2026, selling an estimated $43.1K and leaving 14,779 shares worth $47.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

State of Wyoming first reported a position in NAGE in Q4 2021 and has held it in 9 quarters since. The position peaked at $397K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

State of Wyoming held 14,779 shares of Niagen Bioscience worth $47.1K as of Q2 2026.
State of Wyoming sold 10,626 Niagen Bioscience shares in Q2 2026, an estimated $43.1K.
Niagen Bioscience made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1700 holding.
State of Wyoming first reported a position in Niagen Bioscience in Q4 2021 and has held it in 9 quarters since.
State of Wyoming's Niagen Bioscience position peaked at $397K in Q3 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.